MARAVAI LIFESCIENCES HLDGS I's ticker is MRVI and the CUSIP is 56600D107. A total of 228 filers reported holding MARAVAI LIFESCIENCES HLDGS I in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $26,597 | -12.3% | 2,659,689 | +9.0% | 0.04% | +2.3% |
| Q2 2023 | $30,344 | -32.2% | 2,441,175 | -23.5% | 0.04% | -25.4% |
| Q1 2023 | $44,727 | -6.1% | 3,192,500 | -4.0% | 0.06% | -9.2% |
| Q4 2022 | $47,609 | -99.9% | 3,326,948 | +118.5% | 0.06% | +18.2% |
| Q3 2022 | $38,875,000 | -27.0% | 1,522,700 | -18.8% | 0.06% | -12.7% |
| Q2 2022 | $53,269,000 | +65.4% | 1,875,000 | +105.3% | 0.06% | +65.8% |
| Q1 2022 | $32,209,000 | +41.1% | 913,200 | +67.6% | 0.04% | +35.7% |
| Q4 2021 | $22,827,000 | -51.0% | 544,800 | -42.7% | 0.03% | -53.3% |
| Q3 2021 | $46,630,000 | +73.3% | 950,081 | +47.3% | 0.06% | +76.5% |
| Q2 2021 | $26,908,000 | – | 644,800 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GTCR LLC | 21,681,033 | $764,690,000 | 24.22% |
| Nekton Capital Ltd. | 1,111,102 | $39,189,000 | 9.66% |
| Pavadi Capital LLC | 133,279 | $4,701,000 | 4.14% |
| Curi Wealth Management, LLC | 420,446 | $14,829,000 | 2.57% |
| Select Equity Group, L.P. | 19,100,056 | $673,659,000 | 2.18% |
| Ownership Capital B.V. | 4,205,521 | $148,329,000 | 1.96% |
| Beck Bode, LLC | 167,969 | $5,924,000 | 1.34% |
| Parkman Healthcare Partners LLC | 77,389 | $2,730,000 | 0.80% |
| STONE RUN CAPITAL, LLC | 55,285 | $1,960,000 | 0.72% |
| Champlain Investment Partners, LLC | 3,582,530 | $126,356,000 | 0.65% |